Acadian Asset Management’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-127,404
Closed -$96K 2137
2024
Q3
$96K Sell
127,404
-199,571
-61% -$262K ﹤0.01% 1608
2024
Q2
$587K Buy
326,975
+62,628
+24% +$181K ﹤0.01% 1146
2024
Q1
$1.26M Sell
264,347
-34,172
-11% -$120K ﹤0.01% 781
2023
Q4
$864K Sell
298,519
-70,985
-19% -$112K ﹤0.01% 901
2023
Q3
$498K Sell
369,504
-52,122
-12% -$91.3K ﹤0.01% 1006
2023
Q2
$905K Buy
421,626
+6,136
+1% +$14.9K ﹤0.01% 906
2023
Q1
$1.21M Buy
415,490
+373,782
+896% +$1.88M 0.01% 834
2022
Q4
$284K Buy
41,708
+38,022
+1,032% +$179K ﹤0.01% 1200
2022
Q3
$11K Buy
+3,686
New +$13.4K ﹤0.01% 1636
2021
Q4
Sell
-3,896
Closed -$25K 1845
2021
Q3
$25K Buy
+3,896
New +$37.4K ﹤0.01% 1635
2020
Q2
Sell
-22,847
Closed -$43K 2335
2020
Q1
$43K Buy
+22,847
New +$71.4K ﹤0.01% 1536

Other funds holding STIM

Acadian Asset Management's STIM Position: Q4 2024 in Review

Acadian Asset Management sold out of Neuronetics (STIM) in Q4 2024, closing a stake of 127,404 shares — an estimated $96K sold.

Acadian Asset Management first reported a position in STIM in Q1 2020 and held it in 11 quarters. The position peaked at $1.26M in Q1 2024. 45 funds tracked by Wall St. Rank hold STIM as of Q4 2024.

  • Acadian Asset Management reported no remaining Neuronetics position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 127,404 Neuronetics shares in Q4 2024, an estimated $96K.
  • Acadian Asset Management first reported a position in Neuronetics in Q1 2020 and held it in 11 quarters.
  • Acadian Asset Management's Neuronetics position peaked at $1.26M in Q1 2024.
  • 45 funds tracked by Wall St. Rank held Neuronetics as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.